S&P 500   3,328.55 (-0.03%)
DOW   29,327.77 (-0.07%)
QQQ   223.64 (+0.12%)
AAPL   317.98 (-0.24%)
FB   221.81 (-0.15%)
MSFT   167.34 (+0.14%)
GOOGL   1,488.60 (+0.61%)
AMZN   1,871.42 (+0.36%)
NVDA   248.85 (-0.17%)
BABA   221.84 (-2.46%)
MU   58.92 (+2.19%)
TSLA   541.77 (+6.13%)
AMD   51.16 (+0.45%)
ACB   2.02 (-5.16%)
F   9.18 (+0.22%)
GILD   62.76 (-0.35%)
S&P 500   3,328.55 (-0.03%)
DOW   29,327.77 (-0.07%)
QQQ   223.64 (+0.12%)
AAPL   317.98 (-0.24%)
FB   221.81 (-0.15%)
MSFT   167.34 (+0.14%)
GOOGL   1,488.60 (+0.61%)
AMZN   1,871.42 (+0.36%)
NVDA   248.85 (-0.17%)
BABA   221.84 (-2.46%)
MU   58.92 (+2.19%)
TSLA   541.77 (+6.13%)
AMD   51.16 (+0.45%)
ACB   2.02 (-5.16%)
F   9.18 (+0.22%)
GILD   62.76 (-0.35%)
S&P 500   3,328.55 (-0.03%)
DOW   29,327.77 (-0.07%)
QQQ   223.64 (+0.12%)
AAPL   317.98 (-0.24%)
FB   221.81 (-0.15%)
MSFT   167.34 (+0.14%)
GOOGL   1,488.60 (+0.61%)
AMZN   1,871.42 (+0.36%)
NVDA   248.85 (-0.17%)
BABA   221.84 (-2.46%)
MU   58.92 (+2.19%)
TSLA   541.77 (+6.13%)
AMD   51.16 (+0.45%)
ACB   2.02 (-5.16%)
F   9.18 (+0.22%)
GILD   62.76 (-0.35%)
S&P 500   3,328.55 (-0.03%)
DOW   29,327.77 (-0.07%)
QQQ   223.64 (+0.12%)
AAPL   317.98 (-0.24%)
FB   221.81 (-0.15%)
MSFT   167.34 (+0.14%)
GOOGL   1,488.60 (+0.61%)
AMZN   1,871.42 (+0.36%)
NVDA   248.85 (-0.17%)
BABA   221.84 (-2.46%)
MU   58.92 (+2.19%)
TSLA   541.77 (+6.13%)
AMD   51.16 (+0.45%)
ACB   2.02 (-5.16%)
F   9.18 (+0.22%)
GILD   62.76 (-0.35%)
Log in
(Ad)
I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

NASDAQ:ALNA - Allena Pharmaceuticals Stock Price, Forecast & News

$2.60
-0.08 (-2.99 %)
(As of 01/21/2020 01:20 PM ET)
Today's Range
$2.57
Now: $2.60
$2.68
50-Day Range
$1.91
MA: $2.40
$2.89
52-Week Range
$1.55
Now: $2.60
$9.24
Volume1,814 shs
Average Volume288,226 shs
Market Capitalization$61.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.73
Allena Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States and internationally. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALNA
CUSIPN/A
Phone617-467-4577

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.38 per share

Profitability

Net Income$-35,650,000.00

Miscellaneous

Employees49
Market Cap$61.02 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive ALNA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

Allena Pharmaceuticals (NASDAQ:ALNA) Frequently Asked Questions

What is Allena Pharmaceuticals' stock symbol?

Allena Pharmaceuticals trades on the NASDAQ under the ticker symbol "ALNA."

How were Allena Pharmaceuticals' earnings last quarter?

Allena Pharmaceuticals Inc (NASDAQ:ALNA) issued its earnings results on Wednesday, November, 13th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.49) by $0.08. View Allena Pharmaceuticals' Earnings History.

When is Allena Pharmaceuticals' next earnings date?

Allena Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Allena Pharmaceuticals.

What price target have analysts set for ALNA?

4 equities research analysts have issued 12-month price objectives for Allena Pharmaceuticals' shares. Their forecasts range from $4.00 to $31.00. On average, they expect Allena Pharmaceuticals' share price to reach $20.75 in the next twelve months. This suggests a possible upside of 693.5% from the stock's current price. View Analyst Price Targets for Allena Pharmaceuticals.

What is the consensus analysts' recommendation for Allena Pharmaceuticals?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allena Pharmaceuticals in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allena Pharmaceuticals.

Has Allena Pharmaceuticals been receiving favorable news coverage?

Headlines about ALNA stock have been trending neutral on Tuesday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Allena Pharmaceuticals earned a news sentiment score of 0.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Allena Pharmaceuticals.

Are investors shorting Allena Pharmaceuticals?

Allena Pharmaceuticals saw a drop in short interest in December. As of December 31st, there was short interest totalling 616,200 shares, a drop of 7.2% from the December 15th total of 664,300 shares. Based on an average daily trading volume, of 471,900 shares, the short-interest ratio is currently 1.3 days. Currently, 5.4% of the company's shares are sold short. View Allena Pharmaceuticals' Current Options Chain.

Who are some of Allena Pharmaceuticals' key competitors?

What other stocks do shareholders of Allena Pharmaceuticals own?

Who are Allena Pharmaceuticals' key executives?

Allena Pharmaceuticals' management team includes the folowing people:
  • Dr. Alexey L. Margolin, Co-Founder & Chairman (Age 66)
  • Dr. Louis Brenner, Pres, CEO & Director (Age 49)
  • Mr. Edward J. Wholihan, CFO and VP of Fin. & Admin. (Age 59)
  • Mr. Robert Gallotto, Co-Founder & Strategic Adviser (Age 54)
  • Mr. Hugh Wight, Sr. VP of Technical Operations

When did Allena Pharmaceuticals IPO?

(ALNA) raised $80 million in an IPO on Thursday, November 2nd 2017. The company issued 5,300,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Who are Allena Pharmaceuticals' major shareholders?

Allena Pharmaceuticals' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.21%). View Institutional Ownership Trends for Allena Pharmaceuticals.

Which major investors are buying Allena Pharmaceuticals stock?

ALNA stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for Allena Pharmaceuticals.

How do I buy shares of Allena Pharmaceuticals?

Shares of ALNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Allena Pharmaceuticals' stock price today?

One share of ALNA stock can currently be purchased for approximately $2.62.

How big of a company is Allena Pharmaceuticals?

Allena Pharmaceuticals has a market capitalization of $61.37 million. The company earns $-35,650,000.00 in net income (profit) each year or ($1.72) on an earnings per share basis. Allena Pharmaceuticals employs 49 workers across the globe.View Additional Information About Allena Pharmaceuticals.

What is Allena Pharmaceuticals' official website?

The official website for Allena Pharmaceuticals is http://www.allenapharma.com/.

How can I contact Allena Pharmaceuticals?

Allena Pharmaceuticals' mailing address is ONE NEWTON EXECUTIVE PARK SUITE 202, NEWTON MA, 02462. The company can be reached via phone at 617-467-4577.


MarketBeat Community Rating for Allena Pharmaceuticals (NASDAQ ALNA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  189 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  372
MarketBeat's community ratings are surveys of what our community members think about Allena Pharmaceuticals and other stocks. Vote "Outperform" if you believe ALNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel